Randomized, Double-Blind, Placebo-Controlled Trial of Palonosetron/Dexamethasone with or without Dronabinol for the Prevention of Chemotherapy-induced Nausea and Vomiting after Moderately Emetogenic Chemotherapy.

Trial Profile

Randomized, Double-Blind, Placebo-Controlled Trial of Palonosetron/Dexamethasone with or without Dronabinol for the Prevention of Chemotherapy-induced Nausea and Vomiting after Moderately Emetogenic Chemotherapy.

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Sep 2014

At a glance

  • Drugs Dronabinol (Primary) ; Dexamethasone; Palonosetron
  • Indications Chemotherapy-induced nausea and vomiting
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 13 Nov 2012 Planned end date changed from 1 Mar 2010 to 1 Mar 2013 as reported by ClinicalTrials.gov.
    • 01 Jun 2012 Results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
    • 01 Jun 2012 Primary endpoint has not been met (Number of Participants with Total protection, defined as no vomiting, no rescue therapy, and no nausea) according to the results published at the 48th Annual Meeting of the American Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top